Publications

<< back

• Dr Tamar Nijsten
  Nijsten T, Meuleman L, Schroyens W, Lambert J. Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisolone. Dermatology 2002; 204:365-7.
  
  Nijsten T, De Moor A, Colpaert C, Roberts K, Mahieu L, Lambert J. Restrictive Dermatopathy: a case report and a critical review of all hypothesis of its origin. Ped Dermatol 2002;19:67-72.
  
  Nijsten T, Mentens G, Lambert J. Vascular variant of keratosis lichenoides chronica associated with hypothyroidism and response to tacalcitol and acitretin. Acta Derm Venereol 2002; 82:128-30.
  
  Nijsten T, Stern RS. Genital squamous cell carcinoma in men treated byphotochemotherapy. A cancer registry-based study from 1978 to 1998. [Letter] Br J Dermatol 2002;147:184-5.
  
  Nijsten T, Meuleman L, Lambert J. Neutrophilic eccrine hidradenitis in patient with Behçet’s disease. Br J Dermatol 2002;147:797-800.
  
  Nijsten T, Stern RS. The increased risk of skin cancer is persistent after discontinuation of PUVA: a cohort study. J Invest Dermatol 2003;121:252-258.
  
  Nijsten T, Stern RS. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in psoriasis patients treated with PUVA: a nested cohort study. J Am Acad Dermatol 2003;49:644-650
  
  Nijsten T, Curiel-Lewandrosky C, Kadin ME. Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases. Arch Dermatol 2004;140:306-312
  
  Stern RS, Nijsten T. Insuring Rapid and Robust Safety Assessment. J Invest Dermatol 2004;122: 857-8.
  
  Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004;9:136-9
  
  Mentens G, Nijsten T, Lambert J. Comment on "Recalcitrant tinea corporis as the presenting manifestation of patch-stage mycosis fungoides". [Letter] Cutis 2004;73:378
  
  Nijsten T, Colpaert CC, Vermeulen PB, Harris AL, Van Marck E, Lambert J. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases. Br J Dermatol 2004;151:837-45
  
  Nijsten T, Lapière K, Lambert J. A Patient with Xeroderma Pigmentosum Treated with Imiquimod 5% Cream. J Am Acad Dermatol 2005;52:170-1
  
  Feldman SR, Nijsten T, Margolis DJ, Rolstad T. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing. J Am Acad Dermatol 2005;52:140-1
  
  Gelfand J, Kist J, Nijsten T, Stern RS, Rolstad T, Feldman SR, Margolis DJ. The prevalence of psoriasis in African Americans: Results from a population based study. J Am Acad Dermatol 2005;52:23-6.
  
  Nijsten T, Stern RS, Margolis DJ, Feldman SR, Rolstad T. Members of the National Psoriasis Foundation: more extensive disease and better informed about treatment options. Arch Dermatol 2005;141:19-26
  
  Nijsten T, Margolis DJ, Feldman SR, Rolstad T, Stern RS. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol 2005;52:434-44.
  
  Nijsten T, Geluyckens E, Colpaert CG, Lambert J. Peroxisome proliferator activated receptors , β and  in squamous cell carcinoma and its precursors. J Cut Pathol 2005;32:340-7
  
  Van de Voorde K, Nijsten T, Schelfout K, Moorkens G, Lambert J. Long term use of silver containing nose-drops resulting in systemic argyria. Acta Clin Belgica, 2005;60:33-5
  
  Nijsten T, Leys C, Verbruggen K, Verlinden V, Drieghe J, Stas M, Lambert J, DeGreef H, Garmyn M. A case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination. J Eur Acad Dermatol Venereol, 2005;19:332-9.
  
  Bracke A, Nijsten T, Meuleman L, Lambert J. Lansoprazole-induced subacute lupus erythematodes: 2 cases. Acta Derm Venereol 2005;85:353-4.
  
  Nijsten T, Whalley D, Gelfand J, Margolis DJ, McKenna SP, Stern RS. The psychometric properties of the Psoriasis Disability Index in United States patients. J Invest Dermatol 2005;125:665-72
  
  Gelfand JM, Gladman DD, Mease P, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad, T. Epidemiology of Psoriatic Arthritis in the United States Population. J Am Acad Dermatol 2005;53:573.
  
  Nijsten T, Unaeze J, Stern RS. Refinement and reduction of the Impact of Psoriasis Questionnaire: Classical test theory vs Rasch analysis. Br J Dermatol, 2005;154:692-700
  
  Mentens G, Lambert J, Nijsten T. Polymorphic light eruption may be associated with cigarette smoking and alcohol consumption. Photodermatol, Photoimm, Photomed, 2006; 22: 87-92
  
  Nijsten T, Meads D, McKenna SP. Dimensionality of the Dermatology Life Questionnaire Index (DLQI): a commentary. [Letter] Acta Derm Venereol, 2006;86:284-285
  
  Nijsten T, Sampogana F, Chren MM, Abeni D. Rasch analysis to test and shorten the Skindex-29: Skindex-17. J Invest Dermatol, 2006 126:1244-50
  
  Unaeze J, Nijsten T, Murphy A, Ravichandran C, Stern RS. Impact of psoriasis on health related quality of life decresease over time: an 11-year prospective study. J Invest Dermatol, 2006 126:1480-9
  
  Nijsten T, Lambert J. Dermatologists’ views and opinions about photo(chemo)therapy and conventional systemic psoriasis therapies: results from a national survey in Belgium. Dermatology, 2006;213:123-33.
  
  Nijsten T, Rombouts S, Lambert J. Acne is prevalent but use of its treatments is not among adolescents from the general population. J Eur Acad Dermatol Venereol, 2007;21:163-8.
  
  Rombouts S, Nijsten T, Lambert J. Cigarette smoking and acne in adolescents: a cross-sectional study. J Eur Acad Dermatol Venereol, 2007;21:326-33
  
  Nijsten T, Looman CM, Stern RS. Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol, 2007;143:1113-21
  
  Nijsten T. Level of AGREEment with the British guidelines of the biologicals in psoriasis management. Arch Dermatol, 2007;143:1567-9
  
  Nijsten T, Meads D, de Korte J, Sampogna F, Gelfand JM, Ongenae K, Evers A, Augustin M. Cross cultural inequivalence in dermatology specific health related quality of life instruments among psoriasis patients. J Invest Dermatol, 2007;127:2315-22
  
  de Vries E, Houterman S, Janssen-Heijnen M.L.G., Nijsten T, Eggermont A.M.M., Coebergh J.W.W. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol, 2007;18:1110-6
  
  Nijsten T, Sampogna F, Stern RS, Abeni D. The psychometric properties of the reduced version of the Impact of Psoriasis (IPSO) questionnaire in Italian patients. Dermatology, 2007;215:348-51.
  
  Nijsten T, De Haas ERM, Neumann HAM. Question the obvious. Arch Dermatol, 2007;143:1429-32.
  
  Both H, Essink-Bot ML, Busschbach JJV, Nijsten T. Crital review of generic and dermatology specific health related quality of life instruments. J Invest Dermatol, 2007 127:2726-39.
  
  Koomen ER, Joosse A, Herings RMC, Bergman W, Nijsten T, Guchelaar HG. Effect of statins on melanoma of the skin. Eur J Cancer, 2007 43:2580-9.
  
  van den Bos R, Kockaert MA, Neumann HAM, Nijsten T. Technical review of endovenous laser therapy for varicose veins. Eur J Endovas Vasc Surg, 2008;35(1):88-95
  
  de Vries E, Nijsten T, van Hattem S, Janssen-Heijnen M, Visser O, Schaapveld M, Eggermont AMM, Coebergh JW. Superior survival of female melanoma patients is independent of Breslow thickness, histologic type and tumor site: results from a Dutch general population cancer registry. Ann Oncol, 2008;19(3):583-9
  
  Wakkee M, Thio HB, Spuls PI, de Jong EM, Nijsten T. Evaluation of the reimbursement criteria for biological therapy for psoriasis in the Netherlands. Br J Dermatol, 2008;158:1159-61
  
  Nijsten T, Wakkee M. Psocare: Italy shows the way in postmarketing studies. Dermatology, 2008;217:362-364
  
  de Leeuw J, van Lingen R, Both H, Nijsten T, Tank B, Neumann M. A comparative study on the efficacy of treatment with 585 nm Pulsed Dye Laser and Ultraviolet B-TL01 in plaque type psoriasis. Dermatol Surg, in press
  
  Wakkee M, Lugtenberg M, Spuls PI, Thio B, de Jong EM, Guchelaar, Nijsten T. Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists. Br J Dermatol, 2008;159:426-32
  
  Nijsten T, Sampogna F, Abeni D. Categorization of Skindex-29 scores using mixture analysis. Dermatology, in press
  
  van den Bos R, Arends R, Kockaert M, Neumann M, Nijsten T. Endovenous therapies of lower extremity varicosities are at least as effective as surgical stripping or foam sclerotherapy: meta-analysis and meta-regression of case series and randomized clinical trials. J Vasc Surg, in press
  
  Nijsten T, Spuls PI, Stern RS. STROBE: a beacon for observational studies. Arch Dermatol, 2008;144:1200-4
  
  Koomen ER, Joosse A, Herings R, Casparie M, Guchelaar H, Nijsten T. Oestrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population based case control study. Ann Oncol, in press
  
  Van den Bos RR, Kockaert MA, de Roos KP, Nemuann HAM, Nijsten T. Endovenous Laser Ablation induced complications: review of the literature and new cases. Dermatol Surg, in press
  
  Nijsten T, van den Bos RR, Goldman MP, Kockaert MA, Proebstle TM, Rabe E, Sadick NS, Weiss RA, Neumann MH.Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol. 2008 Oct 1. [Epub ahead of print]
  
  van den Bos RR, Kockaert MA, Neumann HAM Bremmer RH, Nijsten T, van Gemert MJC. Heat conduction from the exceedingly hot fiber tip contributes to endovenous laser ablation of varicose veins. Laser Med Sci